title: The rise and fall of PET and PET/CT: a German perspective.
abstract: PET is being considered a diagnostic commodity in clinical practice worldwide and thus receives increasing attention by health insurances and governmental organizations. In Germany, however, neither PET nor PET/CT are subject to reimbursement. This renders clinical PET and PET/CT imaging a challenge both in a general hospital environment and in private practice. This article describes briefly these challenges, which are not solely related to turf battles and associated costs.
authors.affiliation: PET Diagnose Zentrum, Diagnostisch Therapeutisches Zentrum am Frankfurter Tor, Berlin.
authors.forename: W
authors.initials: W
authors.lastname: Mohnike
mesh_terms: D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000639:trends*; D012051:Reimbursement Mechanisms; D014057:Tomography, X-Ray Computed / Q000639:trends*